Qumea
Qumea provides a unique solution for discreet patient monitoring.
Qumea has raised €11M across 2 funding rounds from 3 investors, most recently a Series A round in Jan 2024. Based in Solothurn, Switzerland; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€11M
€11,236,267
Funding rounds
2
Investors
3
distinct backers
Active since
2021-04
latest 2024-01
Funding by year
EUR raised per yearQumea — funding by year — interactive chart.
Data table
| Qumea — funding by year | |
|---|---|
| 2021 | €1.6M |
| 2024 | €9.6M |
Signals
High confidenceRaise-next likelihood24
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 7y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-30 | Series A | €9.6M | PB Invest,two family offices,Zürcher Kantonalbank | View deal → |
| 2021-04-07 | Seed | €1.6M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData